Brooklyn, NY, United States of America

Manuel Becerra-Flores

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Manuel Becerra-Flores: Innovator in HIV Research

Introduction

Manuel Becerra-Flores is a notable inventor based in Brooklyn, NY (US). He has made significant contributions to the field of HIV research, particularly through his innovative work on recombinant proteins.

Latest Patents

Becerra-Flores holds a patent for a recombinant gp120 protein with a V1-loop deletion. This patent discloses embodiments of recombinant HIV-1 gp120 proteins that contain a V1 deletion. Additionally, it includes gp140, gp145, and gp160 proteins with the same deletion, as well as HIV-1 Env ectodomain trimers containing these protomers. The patent also provides nucleic acid molecules encoding these proteins. In various embodiments, the disclosed recombinant HIV-1 proteins and nucleic acid molecules can be utilized to generate an immune response to HIV-1 in a subject, potentially aiding in the treatment or prevention of HIV-1 infections.

Career Highlights

Throughout his career, Becerra-Flores has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and New York University. His work has been instrumental in advancing the understanding and treatment of HIV.

Collaborations

Becerra-Flores has collaborated with esteemed colleagues such as Genoveffa Franchini and Timothy J Cardozo. Their joint efforts have contributed to the progress in HIV research and the development of innovative solutions.

Conclusion

Manuel Becerra-Flores is a distinguished inventor whose work in HIV research has led to significant advancements in the field. His contributions, particularly through his patented innovations, continue to impact the fight against HIV.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…